Information:
Error:
ID
34411
Description
Non-interventional Study With Pomalidomide (Imnovid®); ODM derived from: https://clinicaltrials.gov/show/NCT02075996
Link
https://clinicaltrials.gov/show/NCT02075996
Keywords
Versions (1)
- 1/17/19 1/17/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 17, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Multiple Myeloma NCT02075996
Eligibility Multiple Myeloma NCT02075996
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Myeloma NCT02075996
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
patients with relapsed or refractory multiple myeloma patients must have received at least two prior lines of treatment (induction therapy followed by stem cell transplantation ± maintenance therapy is considered one prior therapy) and must have progressed under the most recent therapy regimen
boolean
ID.2
Item
adult male and female patients (at least 18 years with no upper age limit)
boolean
ID.3
Item
written informed consent to data collection and pseudonymized data transfer
boolean
ID.4
Item
the conditions of the pregnancy prevention programme must be fulfilled for all patients unless there is reliable evidence that the patient does not have childbearing potential (see summary of product characteristics imnovid®)
boolean
ID.5
Item
other criteria according to summary of product characteristics imnovid®
boolean
ID.6
Item
missing patient's informed consent
boolean
ID.7
Item
pregnant or breast-feeding women
boolean
ID.8
Item
male patients, not capable of complying the required preventive measures (see summary of product characteristics imnovid®)
boolean
ID.9
Item
other criteria according to summary of product characteristics imnovid®
boolean